Published in Acta Endocrinol Suppl (Copenh) on January 01, 1986
A Chinese familial growth hormone deficiency with a deletion of 7.1 kb of DNA. J Med Genet (1990) 0.83
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet (2000) 7.20
Beta-globin locus is linked to the parathyroid hormone (PTH) locus and lies between the insulin and PTH loci in man. Proc Natl Acad Sci U S A (1983) 6.50
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 4.31
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med (2001) 3.60
DNA restriction endonuclease analysis for localization of human beta- and delta-globin genes on chromosome 11. Proc Natl Acad Sci U S A (1979) 3.02
A Design of a PET Detector Using Micro-Channel Plate Photomultipliers with Transmission-Line Readout. Nucl Instrum Methods Phys Res A (2010) 2.77
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet (2000) 2.51
Patterns of polymorphism and linkage disequilibrium suggest independent origins of the human growth hormone gene cluster. Proc Natl Acad Sci U S A (1984) 2.47
Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med (2001) 2.45
Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol (1995) 2.44
A Prototype TOF PET Detector Module Using a Micro-Channel Plate Photomultiplier Tube with Waveform Sampling. Nucl Instrum Methods Phys Res A (2012) 2.17
The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter. Hum Genet (1981) 2.14
Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia. N Engl J Med (1983) 2.06
Antibiotic sensitivity patterns of bacteria causing meningitis. Trop Doct (1990) 2.02
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax (2004) 1.96
Prenatal diagnosis of beta-thalassemias by amniocentesis: linkage analysis using multiple polymorphic restriction endonuclease sites. Blood (1980) 1.73
Prenatal diagnosis of sickle cell anemia by restriction and endonuclease analysis: HindIII polymorphisms in gamma-globin genes extend test applicability. Proc Natl Acad Sci U S A (1980) 1.71
Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci U S A (1981) 1.69
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J (2009) 1.68
siRNA therapeutics: big potential from small RNAs. Gene Ther (2005) 1.66
Molecular recognition of acute myeloid leukemia using aptamers. Leukemia (2009) 1.63
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med (1995) 1.60
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Identification of DNA sequences from a second pathogenicity island of uropathogenic Escherichia coli CFT073: probes specific for uropathogenic populations. J Infect Dis (2001) 1.59
Genetic diseases: diagnosis by restriction endonuclease analysis. J Pediatr (1982) 1.58
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet (1997) 1.52
Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet (1998) 1.51
Combinations of variations in multiple genes are associated with hypertension. Hypertension (2000) 1.51
22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49
P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia. Proc Natl Acad Sci U S A (1987) 1.46
Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome? Arch Dis Child (1980) 1.42
Primary hypothyroidism, central diabetes insipidus and growth hormone deficiency in multisystem Langerhans cell histiocytosis: a case report. Acta Paediatr (1998) 1.40
Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia. Arch Dis Child (1981) 1.40
Huntington's disease: two families with differing clinical features show linkage to the G8 probe. Science (1985) 1.37
Genetic analysis of familial isolated growth hormone deficiency type I. J Clin Invest (1982) 1.36
Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet (1998) 1.35
The molecular genetics of growth hormone deficiency. Hum Genet (1998) 1.33
Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Somat Cell Mol Genet (1985) 1.24
Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci U S A (1988) 1.24
Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab (1999) 1.23
Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr (1992) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Population heterogeneity of the Hpa I restriction site associated with the beta globin gene: implications for prenatal diagnosis. Am J Hum Genet (1981) 1.22
Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension (1991) 1.19
Cervicomedullary compression in young patients with achondroplasia: value of comprehensive neurologic and respiratory evaluation. J Pediatr (1987) 1.18
Two patients with ring chromosome 15 syndrome. Am J Med Genet (1988) 1.17
Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab (1988) 1.17
Anatomic constraints on cognitive theories of category specificity. Neuroimage (2002) 1.15
Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. Eur J Endocrinol (2005) 1.15
Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci U S A (1991) 1.15
Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet (1996) 1.15
Aeromonas hydrophila wound infection. Plast Reconstr Surg (1974) 1.13
Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. Science (1990) 1.13
Prenatal diagnosis of hemoglobinopathies by restriction endonuclease analysis: pregnancies at risk for sickle cell anemia and S--O Arab disease. Johns Hopkins Med J (1979) 1.12
A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet (1997) 1.11
A study of restriction fragment length polymorphisms at the human alpha-1-antitrypsin locus. Hum Genet (1985) 1.11
Seasonal productivity of lizard femoral glands: relationship to social dominance and androgen levels. Physiol Behav (1992) 1.09
Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet (1984) 1.09
Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol (2005) 1.09
Measurement of carbamazepine and its epoxide metabolite by high-performance liquid chromatography, and a comparison of assay techniques for the analysis of carbamazepine. Clin Chem (1977) 1.07
Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Horm Res (2001) 1.06
Etiology of growth hormone deficiency in little, Ames, and Snell dwarf mice. Endocrinology (1983) 1.06
Aeromonas hydrophila infections. Pediatrics (1974) 1.06
Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. PCR Methods Appl (1992) 1.05
Perspectives of longitudinal growth in cystic fibrosis from birth to adult age. Eur J Pediatr (1994) 1.03
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int (1996) 1.02
Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol (Copenh) (1993) 1.02
Teaching about cystic fibrosis carrier screening by using written and video information. Am J Hum Genet (1995) 1.02
Detection of a novel arginine vasopressin defect by dideoxy fingerprinting. J Clin Endocrinol Metab (1993) 1.01
Prenatal diagnosis of lethal perinatal osteogenesis imperfecta (OI type II). J Pediatr (1982) 1.01
Respiratory complications of achondroplasia. J Pediatr (1983) 1.00
Expansion of genetic services utilizing a general genetic counseling clinic. J Genet Couns (2013) 1.00
Unequal crossing-over: a common basis of single alpha-globin genes in Asians and American blacks with hemoglobin-H disease. Blood (1980) 0.99
18p monosomy with GH-deficiency and empty sella: good response to GH-treatment. Clin Genet (1995) 0.99
The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab (1998) 0.98
DNA analysis of cystic fibrosis in Brazil by direct PCR amplification from Guthrie cards. Am J Med Genet (1993) 0.98
Skeletal muscle histology and biochemistry of an elite sprinter, the African cheetah. J Comp Physiol B (1997) 0.97
Familial growth hormone deficiency resulting from a 7.6 kb deletion within the growth hormone gene cluster. Am J Med Genet (1986) 0.97
Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr (1978) 0.97
Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. Am J Hum Genet (1991) 0.96
Allelic variations in the human growth hormone-1 gene promoter of growth hormone-deficient patients and normal controls. Eur J Endocrinol (1997) 0.96
Carrier testing strategy in haemophilia A. Lancet (1986) 0.94
Cystic fibrosis: relationship between clinical status and F508 deletion. J Pediatr (1991) 0.94
Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States. Genomics (1991) 0.94
Auxological, ophthalmological, neurological and MRI findings in 25 Austrian patients with septo-optic dysplasia (SOD). Preliminary data. Horm Res (2002) 0.92
Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension. Clin Genet (2010) 0.92
Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal age. Hum Genet (1999) 0.91
Why does the human factor IX gene have a G + C content of 40%? Am J Hum Genet (1991) 0.91
Genomic organization of a human cystine transporter gene (SLC3A1) and identification of novel mutations causing cystinuria. Kidney Int (1997) 0.91
Hypoplasia of the corpus callosum and growth hormone deficiency in the XXXXY syndrome. Am J Med Genet (1992) 0.91
Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib. J Clin Endocrinol Metab (2001) 0.90
Kinin-induced prostaglandin release in rat colon does not display serosal/mucosal 'sidedness' after epithelial removal. Br J Pharmacol (1986) 0.90
Raymond's syndrome following petrosal sinus sampling. Acta Neurochir (Wien) (1994) 0.90
The effect of 2-acetyl-4-tetrahydroxybutylimidazole on lymphocyte subsets in peripheral blood of the rat. Int J Immunopharmacol (1989) 0.90
Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification products. J Clin Endocrinol Metab (1992) 0.90
[Septo-optic dysplasia and growth hormone deficiency. De Morsier-syndrome (author's transl)]. Monatsschr Kinderheilkd (1980) 0.89